Editorial Methodology
How PeptideStack researches, cites, and reviews peptide content. Sources, update cadence, and the team behind the site.
How we research each peptide
Every peptide profile on PeptideStack starts from the primary literature. We prioritise sources in this order:
- Peer-reviewed studies indexed on PubMed / PMC.
- Registered trials on ClinicalTrials.gov.
- Regulatory documents from the FDA, EMA, WADA, and USADA.
- Secondary sources (clinic sites, news) only when the primary source is unclear or paywalled.
How we write
We draft peptide profiles with the help of large-language models, then check every claim against the primary source it cites. We link the source inline so readers can verify for themselves. We do not recommend dosages for human use — any numbers appearing on the site reflect what researchers used in cited studies.
Update cadence
Each peptide page carries a Last reviewed date. We refresh profiles when new clinical trials publish, when regulatory status changes (e.g. FDA scheduling, WADA list updates), or when a reader flags an error. Blog posts are revised the same way.
Corrections
Found an error? Email corrections to the address in the site footer, or open an issue on our GitHub. We correct with an updated date and a change note.
What we are — and are not
PeptideStack is an informational reference. We are not a clinic, pharmacy, or prescriber. We do not provide medical advice. Many peptides listed here are research compounds that are not FDA-approved for human use. Consult a qualified healthcare provider before using any compound.